BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hong Y, Lee JH, Jeong KW, Choi CS, Jun HS. Amelioration of muscle wasting by glucagon-like peptide-1 receptor agonist in muscle atrophy. J Cachexia Sarcopenia Muscle 2019;10:903-18. [PMID: 31020810 DOI: 10.1002/jcsm.12434] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Ehlers L, Bannert K, Rohde S, Berlin P, Reiner J, Wiese M, Doller J, Lerch MM, Aghdassi AA, Meyer F, Valentini L, Agrifoglio O, Metges CC, Lamprecht G, Jaster R. Preclinical insights into the gut-skeletal muscle axis in chronic gastrointestinal diseases. J Cell Mol Med 2020;24:8304-14. [PMID: 32628812 DOI: 10.1111/jcmm.15554] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Yamada S, Ogura Y, Inoue K, Tanabe J, Sugaya T, Ohata K, Nagai Y, Natsuki Y, Hoshino S, Watanabe S, Ichikawa D, Kimura K, Shibagaki Y, Kamijo-Ikemori A. Effect of GLP-1 receptor agonist, liraglutide, on muscle in spontaneously diabetic torii fatty rats. Mol Cell Endocrinol 2022;539:111472. [PMID: 34606964 DOI: 10.1016/j.mce.2021.111472] [Reference Citation Analysis]
3 Anker MS, Springer J, Coats AJ, von Haehling S. The 10th year of the Journal of Cachexia, Sarcopenia and Muscle. J Cachexia Sarcopenia Muscle 2020;11:1390-5. [PMID: 33340288 DOI: 10.1002/jcsm.12657] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Madhu D, Khadir A, Hammad M, Kavalakatt S, Dehbi M, Al-mulla F, Abubaker J, Tiss A. The GLP-1 analog exendin-4 modulates HSP72 expression and ERK1/2 activity in BTC6 mouse pancreatic cells. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 2020;1868:140426. [DOI: 10.1016/j.bbapap.2020.140426] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Nguyen TTN, Choi H, Jun HS. Preventive Effects of Dulaglutide on Disuse Muscle Atrophy Through Inhibition of Inflammation and Apoptosis by Induction of Hsp72 Expression. Front Pharmacol 2020;11:90. [PMID: 32153405 DOI: 10.3389/fphar.2020.00090] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
6 Abdulla H, Phillips BE, Wilkinson DJ, Limb M, Jandova T, Bass JJ, Rankin D, Cegielski J, Sayda M, Crossland H, Williams JP, Smith K, Idris I, Atherton PJ. Glucagon-like peptide 1 infusions overcome anabolic resistance to feeding in older human muscle. Aging Cell 2020;19:e13202. [PMID: 32744385 DOI: 10.1111/acel.13202] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
7 Huang H, Wang T, Yao S, Lin P, Chang JC, Peng L, Chen L, Yen DH. Gastric Mobility and Gastrointestinal Hormones in Older Patients with Sarcopenia. Nutrients 2022;14:1897. [DOI: 10.3390/nu14091897] [Reference Citation Analysis]
8 Park BG, Kim GM, Lee HJ, Ryu JH, Kim DH, Seong JY, Kim S, Park ZY, Kim YJ, Lee J, Kim JI. Antiobesity therapeutics with complementary dual-agonist activities at glucagon and glucagon-like peptide 1 receptors. Diabetes Obes Metab 2021. [PMID: 34491605 DOI: 10.1111/dom.14546] [Reference Citation Analysis]
9 Mankhong S, Kim S, Moon S, Kwak HB, Park DH, Kang JH. Experimental Models of Sarcopenia: Bridging Molecular Mechanism and Therapeutic Strategy. Cells 2020;9:E1385. [PMID: 32498474 DOI: 10.3390/cells9061385] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
10 Jang J, Park S, Kim Y, Jung J, Lee J, Chang Y, Lee SP, Park BC, Wolfe RR, Choi CS, Kim IY. Myostatin Inhibition-Induced Increase in Muscle Mass and Strength Was Amplified by Resistance Exercise Training, and Dietary Essential Amino Acids Improved Muscle Quality in Mice. Nutrients 2021;13:1508. [PMID: 33947024 DOI: 10.3390/nu13051508] [Reference Citation Analysis]
11 Ishii S, Nagai Y, Kato H, Fukuda H, Tanaka Y. Effect of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin on Muscle Mass and the Muscle/Fat Ratio in Patients With Type 2 Diabetes. J Clin Med Res 2020;12:122-6. [PMID: 32095182 DOI: 10.14740/jocmr4078] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Liu R, Li G, Ma H, Zhou X, Wang P, Zhao Y. Transcriptome profiling of the diaphragm in a controlled mechanical ventilation model reveals key genes involved in ventilator-induced diaphragmatic dysfunction. BMC Genomics 2021;22:472. [PMID: 34172008 DOI: 10.1186/s12864-021-07741-9] [Reference Citation Analysis]
13 Takahashi F, Hashimoto Y, Kaji A, Sakai R, Okamura T, Kitagawa N, Okada H, Nakanishi N, Majima S, Senmaru T, Ushigome E, Hamaguchi M, Asano M, Yamazaki M, Fukui M. Sarcopenia Is Associated With a Risk of Mortality in People With Type 2 Diabetes Mellitus. Front Endocrinol (Lausanne) 2021;12:783363. [PMID: 34858351 DOI: 10.3389/fendo.2021.783363] [Reference Citation Analysis]
14 Byeon HR, Jang SY, Lee Y, Kim D, Hong MG, Lee D, Shin JH, Seo JG. New Strains of Akkermansia muciniphila and Faecalibacterium prausnitzii are Effective for Improving the Muscle Strength of Mice with Immobilization-Induced Muscular Atrophy. J Med Food 2022;25:565-75. [PMID: 35708632 DOI: 10.1089/jmf.2021.K.0148] [Reference Citation Analysis]
15 Omura T, Araki A. Skeletal muscle as a treatment target for older adults with diabetes mellitus: The importance of a multimodal intervention based on functional category. Geriatr Gerontol Int 2022. [PMID: 34986525 DOI: 10.1111/ggi.14339] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Hong Y, Lee JH, Jeong KW, Choi CS, Jun HS. Amelioration of muscle wasting by glucagon-like peptide-1 receptor agonist in muscle atrophy. J Cachexia Sarcopenia Muscle 2019;10:903-18. [PMID: 31020810 DOI: 10.1002/jcsm.12434] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]
17 Choi HJ, Yeon MH, Jun HS. Schisandrae chinensis Fructus Extract Ameliorates Muscle Atrophy in Streptozotocin-Induced Diabetic Mice by Downregulation of the CREB-KLF15 and Autophagy-Lysosomal Pathways. Cells 2021;10:2283. [PMID: 34571935 DOI: 10.3390/cells10092283] [Reference Citation Analysis]
18 van Krimpen SJ, Jansen FAC, Ottenheim VL, Belzer C, van der Ende M, van Norren K. The Effects of Pro-, Pre-, and Synbiotics on Muscle Wasting, a Systematic Review-Gut Permeability as Potential Treatment Target. Nutrients 2021;13:1115. [PMID: 33805286 DOI: 10.3390/nu13041115] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Ma XY, Chen FQ. Effects of anti-diabetic drugs on sarcopenia: Best treatment options for elderly patients with type 2 diabetes mellitus and sarcopenia. World J Clin Cases 2021; 9(33): 10064-10074 [PMID: 34904076 DOI: 10.12998/wjcc.v9.i33.10064] [Reference Citation Analysis]
20 Shang Y, Kuang M, Wang Z, Huang Y, Liu L, Zhao X, Zhang R, Zhao Y, Peng R, Sun S, Yang Q, Yang Z. An Ultrashort Peptide-Based Supramolecular Hydrogel Mimicking IGF-1 to Alleviate Glucocorticoid-Induced Sarcopenia. ACS Appl Mater Interfaces 2020;12:34678-88. [DOI: 10.1021/acsami.0c09973] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
21 Yin L, Chen X, Li N, Jia W, Wang N, Hou B, Yang H, Zhang L, Qiang G, Yang X, Du G. Puerarin ameliorates skeletal muscle wasting and fiber type transformation in STZ-induced type 1 diabetic rats. Biomed Pharmacother 2021;133:110977. [PMID: 33249280 DOI: 10.1016/j.biopha.2020.110977] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
22 Kim TY, Park KT, Choung SY. Codonopsis lanceolata and its active component Tangshenoside I ameliorate skeletal muscle atrophy via regulating the PI3K/Akt and SIRT1/PGC-1α pathways. Phytomedicine 2022;100:154058. [PMID: 35349834 DOI: 10.1016/j.phymed.2022.154058] [Reference Citation Analysis]
23 Priego T, Martín AI, González-Hedström D, Granado M, López-Calderón A. Role of hormones in sarcopenia. Vitam Horm 2021;115:535-70. [PMID: 33706961 DOI: 10.1016/bs.vh.2020.12.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
24 Anker MS, von Haehling S, Springer J. Blocking myostatin: muscle mass equals muscle strength? J Cachexia Sarcopenia Muscle 2020;11:1396-8. [PMID: 33340286 DOI: 10.1002/jcsm.12647] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
25 Grannell A, Martin WP, Dehestani B, Al-Najim W, Murphy JC, le Roux CW. Liraglutide Does Not Adversely Impact Fat-Free Mass Loss. Obesity (Silver Spring) 2021;29:529-34. [PMID: 33528919 DOI: 10.1002/oby.23098] [Reference Citation Analysis]
26 Liu L, Hu R, You H, Li J, Liu Y, Li Q, Wu X, Huang J, Cai X, Wang M, Wei L. Formononetin ameliorates muscle atrophy by regulating myostatin-mediated PI3K/Akt/FoxO3a pathway and satellite cell function in chronic kidney disease. J Cell Mol Med 2021;25:1493-506. [PMID: 33405354 DOI: 10.1111/jcmm.16238] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
27 Khin PP, Hong Y, Yeon M, Lee DH, Lee JH, Jun HS. Dulaglutide improves muscle function by attenuating inflammation through OPA-1-TLR-9 signaling in aged mice. Aging (Albany NY) 2021;13:21962-74. [PMID: 34537761 DOI: 10.18632/aging.203546] [Reference Citation Analysis]
28 Anker MS, Anker SD, Coats AJS, von Haehling S. The Journal of Cachexia, Sarcopenia and Muscle stays the front-runner in geriatrics and gerontology. J Cachexia Sarcopenia Muscle 2019;10:1151-64. [PMID: 31821753 DOI: 10.1002/jcsm.12518] [Reference Citation Analysis]
29 Zhou L, Zhang T, Shao W, Lu R, Wang L, Liu H, Jiang B, Li S, Zhuo H, Wang S, Li Q, Huang C, Lin D. Amiloride ameliorates muscle wasting in cancer cachexia through inhibiting tumor-derived exosome release. Skelet Muscle 2021;11:17. [PMID: 34229732 DOI: 10.1186/s13395-021-00274-5] [Reference Citation Analysis]
30 Kato H, Watanabe H, Imafuku T, Arimura N, Fujita I, Noguchi I, Tanaka S, Nakano T, Tokumaru K, Enoki Y, Maeda H, Hino S, Tanaka M, Matsushita K, Fukagawa M, Maruyama T. Advanced oxidation protein products contribute to chronic kidney disease-induced muscle atrophy by inducing oxidative stress via CD36/NADPH oxidase pathway. J Cachexia Sarcopenia Muscle 2021. [PMID: 34599649 DOI: 10.1002/jcsm.12786] [Reference Citation Analysis]
31 Hunt LC, Graca FA, Pagala V, Wang YD, Li Y, Yuan ZF, Fan Y, Labelle M, Peng J, Demontis F. Integrated genomic and proteomic analyses identify stimulus-dependent molecular changes associated with distinct modes of skeletal muscle atrophy. Cell Rep 2021;37:109971. [PMID: 34758314 DOI: 10.1016/j.celrep.2021.109971] [Reference Citation Analysis]
32 Handelsman Y, Muskiet MHA, Meneilly GS. Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine. Adv Ther 2019;36:3321-39. [PMID: 31646466 DOI: 10.1007/s12325-019-01126-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Nishi H, Takemura K, Higashihara T, Inagi R. Uremic Sarcopenia: Clinical Evidence and Basic Experimental Approach. Nutrients 2020;12:E1814. [PMID: 32570738 DOI: 10.3390/nu12061814] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
34 Yeon M, Choi H, Jun HS. Preventive Effects of Schisandrin A, A Bioactive Component of Schisandra chinensis, on Dexamethasone-Induced Muscle Atrophy. Nutrients 2020;12:E1255. [PMID: 32354126 DOI: 10.3390/nu12051255] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]